Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.14 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |